Mid-term results of endovascular aneurysm repair with branched and fenestrated endografts  by Muhs, Bart E. et al.
From the Society for Vascular Surgery
Mid-term results of endovascular aneurysm repair
with branched and fenestrated endografts
Bart E. Muhs, MD,ab Eric L. G. Verhoeven, MD, PhD,a Clark J. Zeebregts, MD, PhD,a
Ignace F. J. Tielliu, MD,a Ted R. Prins, MD,a Hence J. M.Verhagen, MD, PhD,b and
Jan J. A. M. van den Dungen, MD, PhD,a Groningen and Utrecht, The Netherlands
Purpose: The technique of fenestrated and branched endovascular aneurysm repair (EVAR) has been used for the
treatment a variety of aortic aneurysms. Although technically successful, longer-term results have been lacking. This
article reports on the mid-term results of aneurysm repair with fenestrated and branched endografts from a European
center with a large endovascular experience.
Methods: Between 2001 and 2005, 38 patients were prospectively enrolled in a single institution, investigational device
protocol database. Indications for fenestrated or branched EVAR included unfavorable anatomy for traditional EVAR
and an abdominal aortic aneurysm >5.5 cm in maximum diameter. Customized stent-grafts were either fenestrated or
branched and based on the Zenith system. Data were analyzed on an intention-to-treat basis. Differences between groups
were determined using analysis of variance with P < .05 considered significant.
Results: The mean (SD) follow-up was 25.8  12.7 months (median, 25.0 months; range, 9 to 46 months), and no
patients were lost to follow-up. All cause mortality was 13% (5/38), with all deaths occurring within the first
postoperative year; 30-day mortality was 2.6%. No patient died during the operation. Completion angiography
demonstrated successful sealing in 37 of 38 patients and an overall operative visceral vessel perfusion rate of 94% (82/87).
Cumulative visceral branch patency was 92% at 46months. Stent occlusions, when they did occur, all happened within the
first postoperative year. All postoperative occlusions occurred in unstented fenestrations or scallops. No occlusions
occurred in stented vessels. The difference in serum creatinine preoperatively and postoperatively at 6 months, 1, 2, and
3 years was not significant (P  NS). No patient required dialysis. The aneurysm sac size decreased significantly during
the first year and then remained stable (P< .05). Limb perfusion as assessed by the ankle/brachial index was not affected
by the presence of a fenestrated or branched endograft.
Conclusions:The intermediate-term results of fenestrated and branched endografts support their continued use in patients
with anatomic contraindications for standard EVAR. Close surveillance is mandatory for early identification of visceral or
branched vessel stenosis and preocclusion. All cases of failure appear to occur during the first year and then level off in
subsequent longer-term follow-up. This includes death, secondary interventions, branch vessel patency, and complica-
tions. As the procedure matures, long-term results and randomized clinical trials will ultimately be required to determine
the safety, efficacy, and stability of this system. (J Vasc Surg 2006;44:9-15.)Endovascular aneurysm repair (EVAR) emerged from
infancy not more than 15 years ago to become a primary
treatment modality for properly selected patients.1 Well
controlled trials comparing EVAR with traditional open
aneurysm surgery have demonstrated comparable out-
comes between the two groups.2-4 The perioperative sur-
vival advantage of EVAR vs open repair is lost in longer-
term follow-up.5 Nevertheless, properly selected patients
treated with EVAR can anticipate the immediate benefits of
improved outcome, shorter hospital stay, less surgical mor-
bidity, and a quicker return to normal activities.3,4
With these reported benefits of an endovascular ap-
proach, both patients and physicians have attempted to
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doi:10.1016/j.jvs.2006.02.056increase the percentage of abdominal aortic aneurysm
(AAA) patients suitable for EVAR. Furthermore, a different
patient population with complex aneurysms can be treated
with an endovascular approach. These patients might oth-
erwise be subjected to greater perioperative risk if treated
with an open surgical operation.
The primary limitation to successful endovascular re-
pair of AAAs has been unfavorable anatomy, which most
often includes a short (15 mm) and angulated (60°)
proximal neck, a reverse cone-shaped neck, small access
vessels, inadequate working length, and aneurysms that
include proximal or distal branch vessels.6-8 Of these, a
good proximal neck is crucial and represents the most
common contraindication to standard EVAR with com-
mercially available devices.9,10
In 1999, customized, fenestrated stent-grafts emerged as
a potential solution tomanyof the problems limitingEVAR in
anatomically unfavorable patients.11 Since that initial report,
fenestrated EVAR devices are now commercially available.
These devices have obtained the CE mark in Europe and are
currently undergoing clinical trials in the United States.
In addition to fenestrated endografting for aneurysms
with short infrarenal necks, branched techniques have been
9
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aneurysms.12,13 Technical and short-term results have been
promising with both fenestrated and branched tech-
niques.14 The two largest series from Europe and North
America report on a combined total of 50 patients treated
with a customized fenestrated endograft placed proximal to
the renal arteries.15,16 In these two series, 129 visceral
vessels were incorporated into the grafts, with 128 vessels
patent at the end of the procedure.
These trials reported on only short-term results with a
mean follow-up of 10 months. During the immediate
follow-up, concerns were raised about late visceral vessels
stenosis, endoleaks, and a permanent renal impairment. A
subset analysis of 72 patients treated with fenestrated en-
dografts during a 6-month mean follow-up demonstrated a
significant risk of adverse renal events in patients with
baseline renal insufficiency (39%) and also in those without
(16%).17
The technique has matured, and implantation of both
fenestrated and branched endografts for the treatment a
variety of aneurysms has been accomplished. Although
technically successful, longer-term results have been lack-
ing. This article reports on the mid-term results of fenes-
trated and branched endografts from a European center
with a large endovascular experience.
MATERIAL AND METHODS
Patients. Between November 2001 and January
2005, 38 patients were prospectively enrolled in a single
institution, investigational device protocol database. The
research protocol was reviewed and approved by the Insti-
tutional Review Board. Informed consent was obtained for
all research patients.
Indications for fenestrated or branched EVAR included
unfavorable anatomy for traditional EVAR and an AAA
5.5 cm in maximum diameter. Patients with short necks,
defined as neck length 10 mm, reverse cone-shaped
necks, and aneurysms including visceral vessels were all
included in this series. The surgical team decided which
visceral vessels should be included based on obtaining a safe
and reasonable likelihood of successful and durable aneu-
rysm exclusion while minimizing complexity and potential
complications. Customized devices were used to include
visceral vessels deemed critical for patient survival and qual-
ity of life. In this series, 30 patients presented with short
necks and eight patients with thoracoabdominal or supra-
renal aneurysms.
Imaging evaluation included thin cut (3 mm) spiral
computed tomography angiography (CTA) with axial and
coronal reconstructions to evaluate anatomy. Contrast an-
giography was used when deemed necessary for additional
anatomic information.
Customized stent-grafts were either fenestrated or
branched and based on the Zenith system (William A.
Cook Australia, Ltd., Brisbane, Australia) as described else-
where.18 Four types of customizable options were used:
scallops, large and small fenestrations, and branch sites (Fig
1). Radiopaque markers identified fenestrations and branchsites to enable accurate alignment. Anterior and posterior
markers facilitated rotational orientation during insertion
and deployment. Grafts were fitted with diameter-reducing
ties that allowed for only partial deployment before cathe-
terization of side vessels, which allowed for small changes in
orientation and positioning facilitating proper placement.
Thirty modular devices, in which a standard Zenith bifur-
cated endograft without the proximal attachment struts fit
into a peri-visceral component with fenestrations, and eight
custom made devices were utilized.
Fenestrated or branched EVAR proceeded in the oper-
ating theater under general (n  15, 39%), epidural (n 
17, 45%), or local anesthesia (n  6, 16%), based upon
surgeon, anesthetist, and patient preference. Patients were
prehydrated with intravenous solution before the proce-
dure, and urine output was monitored. Imaging was per-
formed using amobile C-arm (OEC9800, General Electric
Medical Systems, Salt Lake City, Utah).
The technique for endograft deployment has been
previously described.15,19,20 Briefly, the stent-graft is
positioned and partially deployed but constrained by the
diameter-reducing ties. Catheterization of the visceral
vessels is performed, the reducing ties are removed, and
then the side stents or stent-grafts are deployed.
Stenotic branch vessels were predilated with standard
angioplasty techniques if the stent or stent-graft could not
be advanced into position. Diseased target vessels were a
relative contraindication, however, so we did not encounter
many unexpected stenotic branch vessels. All branch vessels
underwent postdeployment dilation. An attempt to salvage
all stenotic branch vessels was undertaken. No branch
vessels were unable to be catheterized due to orificial
occlusive disease.
Completion angiography was then performed. Type II
endoleaks were followed, and attempts to fix type I en-
doleaks involved balloon angioplasty and placement of
additional cuffs. No Palmaz stents were used to treat type I
endoleaks, as has been reported by others.
Postoperative evaluation consisted of clinical and labo-
ratory assessment at discharge, 1 month, 6 months, 12
months, and annually thereafter. Helical CT, duplex eval-
uation, and abdominal radiographs were performed at 1
month, 6 months, 12 months, and annually thereafter.
Contrast angiography was performed for suspected type I
endoleak and visceral vessel impairment, with any required
secondary interventions performed at the time of angiog-
raphy.
RESULTS
The patients included in the study all possessed consid-
erable comorbidities that excluded them from open repair
(Table). Indications for fenestrated or branched EVAR
procedures included a short neck (n  30) or thoracoab-
dominal aneurysm (n  8). Thirty-eight patients (31 men,
7 women) were treated between November 2001 and
January 2005 at a single academic institution with expertise
in fenestrated and branched procedures.
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via the common femoral arteries. The mean (SD) proce-
dure time was 192  65 minutes (range, 110 to 360
minutes), and the mean blood loss was 557  581 mL
(range, 100 to 2500 mL). The mean fluoroscopy time was
30  23 minutes (range, 5 to 85 minutes), and 182  62
mL of iodinated contrast material was used per procedure
(range, 80 to 400 mL).
Branched endografts were defined as either a premade
branched device or an endograft in which covered stent-
grafts (Jomed International AB, Helsingborg, Sweden;
Atrium, Hudson, NH) were placed through the fenestra-
tions. Modalities for vessel perfusion included 11 fenestra-
tions alone, 21 fenestrations with bare stents, seven fenes-
trations with covered stents creating a branched device, 43
scallops alone, four scallops with bare stents, and one
premade branched device.
We initially used balloons, but now use guiding cathe-
ters for branch vessel catheterization and stenting. This is
much safer because access is guaranteed. In the balloon
phase, we had to remove the balloon and insert the stent,
which could prove very difficult. The second point is the
Fig 1. Photograph of a branched endograft demonstrates a small
fenestration (thick arrow), a scallop (thin arrow), and a premade
branch (red arrow).flairing. We do it thoroughly, and it is important to balloonthe inside of the stent at the end to avoid postflairing
stenosis.
A preference towards stenting of visceral vessels oc-
curred with experience, and many of the unstented vessels
were in the early cases. The overall operative target vessel
cannulation success rate was 94% (82/87). Eighty-two
visceral or branch vessels were cannulated successfully, and
five branch vessels were not successfully treated.
Three endovascular procedures were considered ini-
tially unsuccessful due to failure to perfuse the target
branch vessels, requiring modification of the operative pro-
cedure. One patient, who initially had two scallops for right
and left accessory renal arteries, was converted to an aor-
touniiliac stent-graft. We were unable to gain access
through an occluded iliac artery. We then abandoned the
fenestrated option and safely placed an aortouniiliac stent.
It is important to note that in this patient, the goal was to
save only the accessory renal arteries. The main renal arter-
ies were uninvolved. Therefore, we determined it was safe
to cover the accessory renal arteries rather than continue
with surgical options that had potentially more morbidity.
This patient did well, with no renal infarcts on postopera-
tive follow-up and a normal serum creatinine value.
Another patient with an endograft, who had one small
right renal artery fenestration, developed a severe stenosis
of the left and a slight narrowing of the right renal arteries
due to improper endograft positioning. The endograft
moved proximally during full deployment, causing the
bilateral renal artery narrowing. This movement occurred
despite wire access to the renal arteries. It was uncertain if
this bilateral narrowing was significant; however, the serum
creatinine concentration started to rise postoperatively. On
postoperative day 1, this patient underwent open reposi-
tioning of the endograft and a bypass from the right iliac to
the right renal artery. The repositioning consisted of open-
ing the aorta and pulling the endograft distally. The left
renal artery was then widely patent, as the cause of the
narrowing was the endograft. The orifice of the right renal
artery was covered after repositioning; therefore, a right
renal artery bypass was performed to restore perfusion. His
The comorbidities for patients undergoing fenestrated or
branched procedures are listed. American Society of
Anesthesiologists (ASA) class is also presented.
Comorbidities Patients (%)
Cardiac 25 (66)
Pulmonary 14 (37)
Hostile abdomen 4 (11)
Advanced age 6 (16)
Bowel/urine fistula 3 (8)
Other 2 (4)
Obesity 2 (4)
ASA I 0 (0)
ASA II 7 (18)
ASA III 27 (71)
ASA IV 4 (11)serum creatinine level rose from a baseline of 70 mmol/L
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lized at 123 mmol/L at the 1-year follow-up.
The final patient underwent a procedure in which an
endograft with four fenestrations was used. This patient
lost one accessory renal artery at the time of surgery.
Postoperatively, the main renal artery on the same side was
occluded 1 month, although it was normal and widely
patent on completion angiography.
Completion angiography demonstrated successful seal-
ing in 37 of 38 patients. One patient demonstrated evi-
dence of a type I endoleak that was not treated at the time
of the initial intervention. This type I endoleak was con-
firmed on postoperative CT scanning. Further investiga-
tion is currently underway regarding this patient. Addition-
ally, seven (18%) patients had radiologic evidence of type II
endoleaks by completion angiography or follow-up CT
scanning. No type III or type IV endoleaks were observed.
Perioperative results. No patient died during the op-
eration. One patient died on postoperative day 8 for a
30-day mortality of 2.6%. In this patient, who died second-
ary to mesenteric ischemia and bowel infarction, an en-
dograft with two renal fenestrations and an superior mes-
enteric artery (SMA) scallop were placed without technical
difficulty, with SMA patency confirmed on completion
angiography. At autopsy the SMA remained patent. The
mesenteric ischemia may have been secondary to embolic
disease after guidewire manipulation or a severe, low flow
state. The patient was classified as American Society of
Anesthesiologists IV, with a preoperative ejection fraction
of only 23%. Perioperative morbidity included two signifi-
cant retroperitoneal bleeding events, two cardiac events
(myocardial infarction, arrhythmia), two surgical site infec-
tions, two nosocomial infections (bladder, lungs), and one
case of significant urinary retention. The mean (SD) hospi-
tal stay was 5.9  2.8 days (range, 3 to 12 days).
Intermediate follow-up. The mean (SD) follow-up
was 25.8 months  12.7 months (median 25.0 months,
Fig 2. All cause mortality was 13% (5/38). All deaths occurred
within the first postoperative year, with an aneurysm cause mortal-
ity of 0%.range 9 to 46 months), with no patients lost to follow-up.All-cause mortality was 13% (5/38), with all deaths occur-
ring within the first postoperative year (Fig 2) and 0% death
from aneurysm rupture. Analyzed on an intention-to-treat
basis, cumulative visceral branch patency was 92% at 46
months. Only three vessels were lost postoperatively, rep-
resenting just 4% of all targeted branch vessels. All of the
postoperative occlusions occurred during the first postop-
erative year in unstented fenestrations or scallops, and no
occlusions occurred in stented vessels (Fig 3).
Secondary interventions were initially needed within
the first year, but thereafter no secondary interventions
were required (Fig 4). One patient experienced mesenteric
ischemia and was found to have a kinked stent-graft in the
SMA. This stent-graft was folded over on itself, partially
occluding flow. There were two, short covered stents and
they started tilting and created a kink. Mesenteric ischemia
developed because this was the patient’s only mesenteric
vessel. This patient was successfully treated with interven-
tional retrieval of one of the stents and placement of a new,
longer stent. The outer stent was removed and replaced by
a longer covered stent (Atrium). The patient remained
asymptomatic after this intervention. Two patients under-
went treatments for persistent type II endoleaks with en-
larging aneurysm sacs. An identical pattern emerged re-
garding complications related to fenestrated and branched
EVAR, with all complications occurring within the first
year, and then an absence of complications during subse-
quent longer-term follow-up (Fig 5).
Average renal function remained unchanged during the
follow-up period (Fig 6). No patient required dialysis. Only
two patients experienced a significant decline in renal func-
tion (increase in serum creatinine concentration of50%),
and each had an additional explanation for this morbidity.
In one patient, the endograft was malpositioned, resulting
in bilateral severe renal artery stenosis. He underwent an
open laparotomy with repositioning of the endograft and a
right renal artery bypass on the first postoperative day. The
Fig 3. Analyzed on an intention-to-treat basis, cumulative vis-
ceral branch patency was 92% at 46 months. Stent occlusions,
when they did occur, all occurred within the first postoperative
year.other patient experienced a cardiac arrest, resulting in renal
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creased significantly during the first year and then remained
stable (Fig 7). Limb perfusion as assessed by the ankle/
brachial index was not affected by the presence of a fenes-
trated or branched endograft.
DISCUSSION
Promising initial results have been reported for primary
juxtarenal aneurysm repair using fenestrated EVAR tech-
niques.15,16 However, the question remains of whether the
intermediate and long-term results will match the expecta-
tions raised by these early reports. Several issues present
themselves when considering the long-term durability of
fenestrated and branched endografts. Fenestrated device
placement necessarily relies on extremely precise imaging
and deployment. Vessel ostia are aligned with very little
margin for error. The early technical and short-term reports
indicate that this exact measurement and deployment can
be successfully accomplished with satisfactory results.
However, we initially believed that the risk of misalignment
would increase with time as changes in aortic morphology
in relation to side branches became more pronounced.
The data from this series, with a mean follow-up of2
years, suggest otherwise. The aortic morphology changes as
the aneurysm shrinks significantly during the first year after
endovascular repair. The aneurysm then remains stable
after 1 year. Branch vessel loss appears to be related primar-
ily to procedure-related difficulties and not to changes in
aortic morphology. All target vessels that occluded, repre-
senting 5% of the total, were lost during the first year.
Thereafter, vessel patency remains quite high. Further-
more, as the technique has evolved, modifications in the
technique will likely result in improved initial target vessel
patency. All of the target vessels that occluded postopera-
tively (one in a small fenestration and two in scallops)
occurred in unstented arteries. Our current practice is to
stent all renal fenestrations, even if they are scallops.
Although the numbers are small, since we have used
Fig 4. There was an initial need for secondary interventions
within the first year, and thereafter no secondary interventions
were required.routine stenting of all renal fenestrations and used rein-forced fenestrations and scallops, we have not experienced
any additional postoperative target vessel occlusions. For
renal arteries, we started using stents to keep the position-
ing perfect, as one cannot rely on perfectly correct preop-
erative measurements. The stents will force each small
fenestration towards its perfect position if needed.
There are concerns about the long-term effect of fenes-
trated endografts on renal function. Several authors noted
an immediate decrease in renal function after graft implan-
tation.16,17,21 Speculation about the etiology of this de-
creased renal function revolves primarily around contrast
nephrotoxicity and periprocedural atheroemboli. These
causes of renal impairment should be limited to only the
short-term results, however, because once the procedure is
completed, the offending mechanisms are no longer
present.
The difference in serum creatinine levels preoperatively
and postoperatively at 6 months, 1, 2, and 3 years was not
significant. We acknowledge that renal artery stenosis
would not likely be detected by serum creatinine measure-
ments. Glomerular filtration rate and renal artery duplex
examinations may provide a better analysis of postoperative
renal function. The previously reported risk of renal impair-
ment may be overstated, however, and is not supported by
our data reporting intermediate-term follow-up. The im-
portance of meticulous technique in renal cannulation and
positioning of the endograft in relation to the renal arteries
cannot be overstated, however.
The low 2.5% incidence (1/38) of type I endoleaks in
this intermediate follow-up period supports the theory that
extending the endograft fixation to a relatively straight and
longer proximal aorta through the use of fenestrations and
side branches does achieve better sealing zones than at-
tempting EVAR with poor aortic neck anatomy.9,10,22 The
fenestrations do not appear to result in increased endoleaks,
which was an initial worry. We believe that with the routine
use of reinforced fenestrations and scallops and covered
Fig 5. Complications occurred within the first year. There was an
absence of complications during subsequent longer-term follow-
up.stenting of all small fenestrations and many scallops, we can
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now use longer stent-grafts in the branched designs, with
close attention given to precise and proper flaring within
the endograft skeleton. We believe that the long stent-
grafts better distribute forces along the branched vessel
with better results. Our 18% type II endoleak rate (7/38) is
comparable to standard EVAR and treated similarly. No
adverse sequela resulted from type II endoleaks, although
they did result in more secondary procedures.
In contrast to our early report, the techniques have
evolved, with more difficult anatomic challenges being met
through the use of side branches and more complicated
fenestrated grafts. However, as our experience has grown,
the complexity and technical demands of the procedure
have also increased. In our experience, this has required a
team approach to endovascular aneurysm repair using fe-
nestrated and branched stent-grafts, which we believe is
important to emphasize as the procedure becomes increas-
ingly accepted.
CONCLUSION
The intermediate-term results of endovascular repair
with fenestrated and branched endografts support their
continued use and evaluation in patients with anatomic
contraindications for standard EVAR. Close surveillance is
mandatory for early identification of visceral or branched
vessel stenosis and preocclusion. Failures appear to occur
during the first year and then level off in subsequent,
longer-term follow-up. This includes death, secondary in-
terventions, branch vessel patency, and complications. In
this respect, the results of repairs with fenestrated and
branched endografts are in agreement with previously pub-
lished standard EVAR series.3,4 As the procedure matures,
long-term results and randomized clinical trials will ulti-
mately be required to determine the safety, efficacy, and
stability of this system.
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